Brought to you by 
OptumRx buys PBM Catamaran for $13bn
08 Jul 2015
Executive Summary
UnitedHealth Group Co.'s OptumRx Inc. acquired Catamaran Corp., a public pharmacy benefits manager, for $13bn in cash, or $61.50 per share (a 25% premium), creating one of the leading PBMs in the US alongside Express Scripts and CVS. The combined OptumRx/Catamaran will be led by Catamaran's existing chairman and CEO Mark Thierer.
Deal Industry
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OptumRx buys PBM Catamaran for $13bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice